A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I

Conditions: Gaucher Disease Type I Interventions: Biological: LY-M001 Injection Sponsors: He Huang; Lingyi Biotech Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials